Sagimet Biosciences closes underwritten offering
Sagimet Biosciences said it closed an underwritten offering of Series A common stock and pre-funded warrants.
Story updates
08:38:41 PM UTC
SquawkNews
Sagimet Biosciences closed an underwritten offering of 8,750,010 Series A shares and pre-funded warrants for 2,750,010 shares, raising approximately $115.0M gross. Proceeds will fund denifanstat programs, TVB-3567 through Phase 2 topline, and general purposes.Material DetailsContext by AI AnalystTh…